Supporting business in screening, understanding, and designing biologicals. With its 30-year track record, KeyGene is in an excellent position to support companies with their toughest R&D challenges in the fields of biostimulants and biocontrol.
Would you like to learn more about the successes R&D can bring to biologicals businesses?
View the recordings of the KeyGene webinar “R&D as a success factor for the biologicals industry” of October 2021.
Digital phenotyping in our state-of-the-art greenhouses allows monitoring crop responses after product application, providing objective and robust data in a
high throughput manner. We have different plant phenotyping platforms that allow testing high numbers of products, or evaluate root and shoot growth over a long period non-destructively. Our trials can include abiotic stresses as well as several soil-borne pathogens.
When your products are microbial-based, characterizing your core collection with our genomic toolbox allows you to classify strains and remove redundancy. Accurate taxonomical classification and identification of potential functionalities can be achieved using a variety of genome sequencing capabilities.
At KeyGene we can specifically design your biocidal screening assay on different scales. We can accommodate in vitro assays, grow plants in growing chambers, or use our greenhouse facilities. We have experience with a variety of relevant crop pathogens.
Elucidation of your product’s mode of action may require different perspectives. Looking at the plant response via transcriptomics, or evaluating the changing composition of the rhizosphere via metagenomics can reveal how exactly the crop benefits from your product.
When zooming in on a biocontrol product, the focus will be on the pathogen and how it is affected by the product.
Being able to understand at all levels how your product functions matters to your R&D team, enabling them to transmit all that knowledge to your technical and sales team, and hence to your customers. Using a scientific approach is the best way to support product claims, also when preparing for the product’s registration phase when claims need to be justified in a scientific manner.
Thorough understanding of existing products will set the basis for developing the next generation of biologicals products. A holistic view of the interactions between plant, product, and their surroundings will be key for the industry's continued development.
KeyGene's KeyPoint platform for random mutagenesis is being used to induce genetic variation in one or multiple pre-defined microbial genes. With that, your favorite strains can be further improved without the disadvantages of a long EU gm-trajectory.
Once you understand the mode of action of different active ingredients, intelligent product combinations can be made and tested for complementary or synergistic effects.
